Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Capital Expenditure | Capital Expenditures Coverage | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 1.25M | 0 | $ -2.19M |
3/31/2025 | $ 987K | 0 | $ -572K |
12/31/2024 | $ 1.28M | 6.78 | $ 8.67M |
9/30/2024 | $ 1.1M | 7.5 | $ 8.28M |
6/30/2024 | $ 1.47M | 0 | $ -2.71M |
3/31/2024 | $ 1.5M | 3.91 | $ 5.87M |
12/31/2023 | $ 1.15M | 0 | $ -1.32M |
9/30/2023 | $ 1.11M | 0 | $ -7.52M |
6/30/2023 | $ 723K | 0 | $ -9.84M |
3/31/2023 | $ 647K | 0 | $ -22.17M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / CapEx
(=) CapEx Coverage
CapEx Coverage for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ -22.24M ] / CapEx [ $ 408K ]
(=) CapEx Coverage [ 0 ]
Minimum
Mar 31, 2024
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 2.21K |
---|---|
min | 0.01 |
max | 17.91 |
average | 4.41 |
median | 3.01 |
std | 4.02 |